Short Population Report (SPR)
Raw HLA typing data intended for publication as an SPR in Human Immunology.
View requirements →AFND Data Submission Guidelines
The Allele Frequency Net Database (AFND) welcomes population data on HLA, KIR, MIC and cytokines to support research in population genetics, immunogenetics and related biomedical fields.
The appropriate submission procedure depends on the type of data you have available and whether you intend to publish your results as a Short Population Report (SPR) in Human Immunology, share data published in another journal, or share unpublished data with the community.
Before preparing your submission, identify which of the following options best describes your data:
Please review the applicable requirements below before submitting your data.
Select the pathway that matches your data and publication plans.
Raw HLA typing data intended for publication as an SPR in Human Immunology.
View requirements →Raw HLA typing data and corresponding frequencies, without preparing an SPR.
View requirements →Allele or genotype/phenotype frequencies when raw typing data are unavailable.
View requirements →Download the appropriate CSV template and send the completed files to the AFND team.
View templates →Choose this option if you have raw HLA typing data and intend to prepare a Short Population Report for publication in Human Immunology.
Since 1 April 2022, Human Immunology has required data submitted to AFND with the intention of preparing an SPR to have been generated using molecular methods and to achieve at least two-field (four-digit) HLA allele resolution.
Data that do not meet these requirements may still be submitted directly to AFND, but they will be evaluated on their merits. Factors such as the uniqueness of the population may be considered.
Meeting the technical requirements does not, by itself, guarantee acceptance for publication.
Note: Consult the SPR submission guidelines when the official instructions become available.
Choose this option if you have raw HLA typing data and corresponding frequency data but do not intend to prepare a Short Population Report for Human Immunology.
Note: Submissions will be reviewed according to AFND's data requirements and assessment procedures.
Choose this option if you have already calculated HLA allele or genotype/phenotype frequencies and do not have raw typing data to submit.
Note: Raw typing data are not required for this pathway, although supporting information may be requested during review.
For KIR, MIC and cytokine submissions, use the corresponding AFND template.
Please use the template corresponding to your data type. If you are submitting multiple data types, indicate clearly which files correspond to each dataset and population.
Regardless of the submission pathway, please provide the information needed to interpret, evaluate and correctly catalogue your data.
Include the applicable information requested in the submission form or template, such as:
Ensure that the submitted frequencies correspond to the stated population and sample size. Specify whether the results represent allele frequencies, genotype frequencies, haplotype frequencies or another data type, as applicable.
Use the required AFND format and provide sufficient information to identify the loci, alleles, genes or markers being reported.
Where applicable, provide:
Please ensure that you have the appropriate permissions to share the data and that any personal or identifiable participant information has been excluded.
Before submitting your complete dataset, check that your files follow the relevant template or data-format specifications.
For direct HLA submissions, follow the designated AFND procedure for uploading or providing raw typing and frequency data, or frequency data alone, according to your selected pathway.
If you are uncertain which submission route to use, contact the AFND team before preparing your files.
After receiving your submission, the AFND team will assess the available information for completeness, consistency and suitability for inclusion in the database.
The review may include:
For submissions intended for an SPR, publication-related eligibility requirements will also apply.
Submitting data does not guarantee acceptance into AFND or publication in Human Immunology. The AFND team will communicate any required follow-up steps.
For questions about data formats, submission requirements or the appropriate submission pathway, please contact the AFND team.
We welcome population data submissions and feedback that help improve AFND and expand the availability of immunogenetic data for the research community.
Contact the AFND team →No. You can submit eligible HLA frequency data directly to AFND without preparing a Short Population Report. Direct submission pathways are also available for HLA raw data and frequency data. KIR, MIC and cytokine data can be submitted using the corresponding templates.
Yes. Data that do not meet the molecular-method and two-field resolution requirements for an SPR may still be submitted directly to AFND and will be evaluated on their merits.
Yes. Use the direct HLA frequency-data submission pathway.
Download the corresponding template, complete the demographic and frequency information, and email the files to the AFND team.
Contact the AFND team with a brief description of your data type, the information available and whether you intend to prepare an SPR. The team can advise you on the appropriate submission procedure.